Senescence halts cell division but can promote inflammation, aiding cancer growth
Live Forever Club - 24-Nov-2024Therapies targeting senescence cells show promise for controlling cancer progression
Join the club for FREE to access the whole archive and other member benefits.
Therapies targeting senescence cells show promise for controlling cancer progression
Targeting senescent cells may prevent disease progression and show promise
Early removal of these cells slows recovery, highlighting their short-term benefits
You can protect yourself by wearing masks, using air purifiers, and avoiding polluted areas
FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
But, senolytic therapy may not be a universal solution for age-related bone loss
This could have implications for developing new therapies
This offers a safer, more effective treatment for age-related diseases
Switching the mice back to a standard diet reduced the damage
It may hinder the development of long-lasting protection against future infections
Potentially leading to breakthroughs in managing chronic diseases
The discovery reveals the body's potential for self-rejuvenation
Developing senotherapeutics to target cellular senescence and treat age-related diseases
While modifying immune cell populations, the drugs also increased ageing biomarkers
Originally used to fight cancer, sound waves surprisingly revive old cells
Green tea improved gut health and boosted the immune system in mice
The treated mice showed better health, including improved metabolism and activity
This could impact how much iron we get from food or supplements
In mice, this therapy was shown to reduce the number of senescent cells
FAST is precise and works with different cell types and microscopes
Senolytic intervention helps to repair the protective barrier of the eyes
Supplementation reduced the buildup of senescent cells in the arteries of aged mice
Cellular senescence can be significantly mitigated by a holistic lifestyle
FDA-approved drug kills zombie cells and improves organ function in elderly mice
Drugs have the potential to revolutionise the way we treat age-related diseases
Mitochondria targeting could lead to new treatments for age-related diseases
The treatment was well-tolerated with no significant changes in brain function
More research is needed to determine the safety and efficacy of senolytics in humans
Three natural compounds identified, paving the way for new treatments
Vaccine not only reduced inflammation, but also improved behavior and awareness in mice
Insights on the evolution of ageing and may help advance regenerative medicine
Artificial intelligence identifies herbal compounds to safely eliminate senescent cells
UBX1325 showed disappointing results in phase II macular degeneration trial - further analysis is required
Machine learning successfully identifies promising senolytic compounds to target ageing and age-related diseases
Corporate shift towards ophthalmology puts senolytics head-to-head against existing treatments
Age-related increase in inflammatory markers p16 and IL-6 was not observed in endurance athletes
Senescent cells have become one of the most promising targets for healthy aging research
Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammation
Scientists are working to bring these new rejuvenation biotechnologies of senolytics to aging humans
Novel therapy killed some senescent cells, rejuvenated others, without harming healthy cells
Grand plan includes creation of imaging datasets, new tools, techniques, and biomarker panels
How senescent neurons lead to Alzheimer’s disease, effect on removal and drugs needed for therapy
BDNF-TrkB pathway shows a lot of promise in lowering senescent cells in older organs
The study is a caution for scientists engaging in self-experimentation with senolytics
Cleara’s novel FOXO4-based treatment approach-ability to eliminate biomarker-positive scarred cells
Eliminating senescent cells rejuvenates the heart's capacity for regeneration in mice
Statistically significant treatment effect for both BCVA and CST was seen at both 12 and 18 weeks
Oxidative DNA damage induce rapid senescence compared with shorter telomeres from repeated cell divisions
Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests
Radiation-induced damage may lessen by removing senescent cells but senolytics may not reverse the damage
in vivo analysis in mice confirms the imaging results against p21 biomarker
Combined approach surprisingly eliminated the negative effects of individual treatments
Le Calvé will chair the Scientific Advisory Board and the Management Committee
Dasatinib+Quercetin restores a-klotho protein, which could combat ageing and disease in older people
Both are leading first generation longevity treatments - even better if they strengthen each other
New class of senotherapeutic drugs that could possibly target various diseases and ageing
Senolytics showed positive effects on rats but trials must confirm these findings on human brain
Funding will ensure the development of a new immunotherapy for age-related diseases
Dasatinib plus quercetin slow down muscle regeneration in young mice
New research claims in removing zombie cells behind aging by vaccination
Improved survival via eliminating old cells - potential candidate to slowdown ageing
Lorna Harries believes dysregulated splicing as a breakthrough senotherapeutic target
New study results show clinical applications in pathological ageing
Boosts immune response by clearing senescent cells; a potential treatment for COVID-19 in humans
Dasatinib and quercetin combo preserves spinal discs to target age-related back pain
NANOG targets multiple ageing mechanisms - insights may help develop new therapies for age-related disorders
Stimulated senescent human umbilical vein cells showed high susceptibility to inflammatory diseases
Most approaches have their limitations but good progress is being made on several fronts
Senolytics for cartilage and bone regeneration in jaw joints, proven effective in mice
Senolytic drugs administration promotes locomotor and sensory recovery
Begun phase 2 trial including patients with early stage of disease to test its safety and effectiveness
New study using biomarkers proved the importance of regular exercise again
Investigational therapy on old mice cleared senescent cells up to 70%, extending life by 20%
DHE slowed senescence in intervertebral discs of mice; but its use in anti-aging is still questionable
Activated immune cells can treat age-related chronic diseases - a potential alternative to senolytics
Vibration treatment eliminates senescence of bone cells - may not be applicable to other tissues
Senolytic Therapy Network aims to take the senotherapeutics from lab to clinic
Establishing a massive database on cellular senescence to improve human health
Detectible senescence-specific biomarker allows development of new drugs for age-related conditions
New plant-based longevity pill that offers better access to many health benefits
NAD+ levels, senescence and chronic inflammation collectively influence ageing
Results in mice suggest that it can increase median lifespan in humans by 15 years
Senolytic drug and cancer drug with quercetin improved age-related cognition
Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soon
With positive results in mice, scientists expect to slow down ageing in humans
Comprehensive review of companies' clinical and financial state of play
Senescence killing drug in mice might unveil new heart attack treatments
Molecular simulations have discovered an enzyme with anti ageing and anti tumour effects
Senolytics to treat cancers - study finds correlation between senescence & survival
Not as easy as taking a pill, but a stunning result on both telomeres and senescent cells
In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing joint pain and stiffness.
The anti-ageing peptide promotes skin health and reduces senescent cell markers
Topical supplement which extends skin span-the period of time your skin is healthy and youthful
Taisho and Insilico collabs to identify novel targets for senolytic drugs
A new approach to treat diabetic macular oedema
Mice study also saw improved cognitive abilities
General feeling that failures are bound to happen - but that their approaches can succeed
Senolytic research is in its nascent stage but no reason why one shouldn't be hopeful
Disappointing first result - but lessons learnt and plenty of other strategies available
Given senolytics are unlikely to ever clear every senescent cell, exercise will still minimise bad effects of those remaining
Old cells will be more young and beautiful
Maybe we need to develop senoplasts like resveratrol as well as senolytics
It may be a new hallmark of ageing, but it's been one of SENS' 7 strategies since it started
It could measure biological age and relative health
Successful in mice, it may help treat many age-related disease in human
Short-term treatment of this drug demonstrated cytotoxicity among other risks
Tested successfully in mice with liver fibrosis and lung cancer
Could lead to new drug discovery against senescent cells and extend lifespan
New study in mice demonstrates an intriguing possibility with senescent cells research
Little evidence of actual beneficial effects (rather than just biomarkers) so not recommended yet
Intriguingly destroys senescent cells without inducing cell destruction
Experiments yielded promising results in efficacy, specificity, and non-toxicity
Hopes are up for it to directly help the cancer research community and patients
Tested in aged mice and turns out that it can rejuvenate tissue stem cells
We'll almost certainly need a combination of drugs so look forward to seeing the results
They found efficient way to increase its senolytic specificity, reduce platelet toxicity
Will senolytics become the panacea to the whole Pandora's box by 100 years into future?
As always, it's complicated, but controlling levels of ATM could be part of a therapy to combat ageing
How senescence can fuel cancer development and how malignant cells induce senescence
We need to recognize normal patterns in order to identify what's abnormal
Including the latest on clinical trials of first-generation senolytics
HDAC inhibitor shows beneficial effects in mice but too toxic for healthy humans
Potential target for drug-based interventions to delay cellular ageing identified
Senescent cells seem to play a major role even in heart diseases
Biomarker caused by glycolysis seen in all types of cancer - exciting possibilities
Senescent cell burden is a marker of disease free years ahead of life
Cellular senescence is now a top research topic and a very messy one in ageing research
It is a comprehensive proteomic database of soluble proteins and exosomal cargo SASP factors
Just like rapamycin, berberine also slows down the senescent process
Solving the mystery of ageing - still at the beginning
Fossel argues for telomerase therapy over senolytics
They have a natural mechanism against cellular senescence and ageing
They're often called zombie cells - and turns out they are. Time to kill them with senolytics!
Phase 1 clinical trial starting early 2020
Is it really possible to develop a drug without side effects?
Many drugs for heart diseases are broad-spectrum senolytics as tested in mice
Research suggests senolytic treatments will be beneficial for at least a few decades
Does this mean that future therapies to slow down ageing may cause cancers as a side effect?
Could help tackle venous thrombosis that becomes a bigger risk with age
Once more confirmed, senolytics reduce senescent cells by that preventing their effect of ageing
Occasional senolytic use may be enough to keep senescent cells at bay
Adjusting the levels of just two molecules in the blood could lead to significant rejuvenation
Aims to prolong the healthspan as well as the lifespan
Removing senescent cells will make us vulnerable to cancer
Prevention of losing nucleotide synthesis ability would result in cells slowly ageing
Promising results in genetically altered mice with Alzheimer’s traits
Unlike cancer, you don't have to kill every senescent cell
nanoMIPs could improve the specificity of senolytics
Initial results must be promising to enrol more patients at highest dosage
Very early days but good to have more senolytics in the pipeline
Physical improvements recorded, but pulmonary function was unchcanged
Next step is to go to an actual large-scale human trial
Includes table of fisetin content in range of fruits and vegetables
Still a long way to go before expanding life span
Mice fed with fisetin diets lived much longer
Fisetin is a very common natural product that has positive effects over health and aging
Killing of senescent (aging) brain cells with an enzyme stopped the progress of dementia
Alternative approaches to tau targets in neurodegenerative disorders
Findings could enhance the treatments to reverse dementia or destroy cancer cells
β-Hydroxybutyrate and OCT4 slow down vascular aging, preventing disease
3 compounds designed to deliver minute amounts of hydrogen to mitochondria inhibit cellular aging
Antoxerene partners with Juvenescence to discover drugs that clear senescent cells
This therapy uses a modified FOXO4 to promote apoptosis in senescent cells
Senolytic cocktail caused improved physical condition of elderly mice
The company is going to test a new Senolytic drug in human trials
The gene for CD36 becomes more active in older cells and it may be key for the aging process
Look forward to seeing the results of the NAD supplement trial
Senescence is usually thought to be irreversible.
Proof-of-concept trials starting that pit senolytic drugs against a range of age-related ailments.
New platform will help to identify additional drugs that target ageing processes more quickly
Researchers commonly determine the presence of senescent cells through the use of the p16ink4a (p16) and ?-galactosidase biomarkers.
A guide for anyone considering self-experimentation.
Researchers used local clearance of senescent cells (in mice) to reduce the development of post-traumatic osteoarthritis and encourage tissue regeneration.
Study directly targets one of the mechanisms that senescent cells use to avoid apoptosis,
Study describes a new way that senescent cells communicate via the expression of integrin membrane proteins.
Growing older results in a build-up of the body’s senescent cells and naturally accumulate with age.
Peter de Keizer of the Erasmus University Medical Center discusses strategy of removing senescent cells.
It is focused on the twofold path of
CellAge is going to develop synthetic promoters which are specific to senescent cells, as promoters that are currently being used to track senescent cells are simply not good enough to be used in therapies.
Unity Biotechnology’s technology jump starts senescent cells into dividing again.
Cells accumulate damage in their DNA.
Cells eventually stop dividing to replace damaged neighbours and to into senescence.
Senolytics, a new class of drugs, might dramatically slow the aging process and so change the face of old age.